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Veryfewstudieshavebeenperformedtoevaluatetheeﬀectofcultureconditionsontheproductionoractivityofactivemetabolites
inalgae.Previousstudiessuggestthatthesynthesisofbioactivecompoundsisstronglyinﬂuencedbyirradiancelevel.Toinvestigate
whether the antiproliferative activity of Udotea ﬂabellum extracts is modiﬁed after cultivation, this green alga was cultured under
four photon ﬂux densities (PFD) for 30 days. After 10, 20, and 30 days, algae were extracted with dichloromethane: methanol and
screened for antiproliferative activity against four human cancer cell lines (laryngeal—Hep-2, cervix—HeLa, cervix squamous—
SiHa and nasopharynx—KB) by SRB assay. Lipid and phenol content were evaluated by standardized methods on algae organic
extracts.After10daysofcultivation,organic U. ﬂabellum extractsshowedasigniﬁcantincreaseinantiproliferativeactivityonHela
and SiHa cells when compared to noncultured algae extracts. Extracts obtained after 10 and 20 days of culture were active on KB
and Hep-2 cells. Total phenol and polyunsaturated fatty acid content in organic extracts changed with cultivation time but not by
irradiance treatment. Extracts from U. ﬂabellum obtained after 10 and 20 days of culture have been selected for fractionation and
isolation of active compounds.
1.Introduction
Natural products and related drugs are used to treat 87% of
all categorized human diseases including bacterial infection,
cancer, and immunological disorders [1]. Approximately
25% of prescribed drugs in the world originate from plants
[2] and over 3000 species of plants have been reported to
haveanticancerproperties[3].Recenttrendsindrugresearch
on natural sources suggest that algae are a promising source
of novel biochemical active substances [4]. To survive in
a competitive environment, marine algae have developed
defensestrategiesthatresultinasigniﬁcantlevelofstructural
chemical diversity that is derived from diﬀerent metabolic
pathways [5]. The eﬀect of culture conditions on the
production or activity of active metabolites in algae has
scarcely been studied and consequently remains poorly
understood. In other alga models, such as the cyanophyte
Scytonema, increasing irradiance gradually increased antibi-
oticproduction[6].Similarly,Spyridiaﬁlamentosa,aredalga
culturedatdiﬀerentlightirradiances,hadcontrastingantibi-
otic activities that were strongly inﬂuenced by irradiance
level [7]. Most recently, extracts obtained from Penicillus
dumetosus cultured at diﬀerent light irradiances displayed
varying antiproliferative activity against diverse cancer cell
lines [8]. The feasibility of algal cultivation can help to
induce adaptations that can be measured through metabolite
synthesis or biological activity. Fully controlled greenhouse-
based cultivation systems have been developed for high-
quality year-round vegetable production for the botanical
drug market [9]. Therefore, a better understanding of the
potential manipulation of algal culture conditions to modify
metabolite synthesis and activity is required.
Tropical green algae in the order Bryopsidales, including
those of the genera Avranvillaea, Caulerpa, Halimeda, Peni-
cillus,a n dUdotea, are noted for the production of sesqui and
diterpenoids, compounds that have also shown antifungal
and antiproliferative activity [5, 10]. Recent studies have
shown that both aqueous and organic extracts of Udotea
ﬂabellum exhibit in vitro antiprotozoal [11, 12]a sw e l l
as cytotoxic and antiproliferative activities on cancer cell
lines [13]. In some cases, the antiproliferative activity of
marine algae extracts has been positively correlated with2 Evidence-Based Complementary and Alternative Medicine
total polyphenol content, suggesting a causal link between
the extract content of polyphenols and phenolic acids [14],
while other authors have reported a variety of fatty acids and
derivatives with antiproliferative eﬀects in diﬀerent cancer
cellmodels[15].Despitetheobservationsofantiproliferative
activity in marine algae, there is limited information on
how this activity may change under contrasting environ-
mental conditions. Therefore, the objective of this study
was to investigate the antiproliferative activity of crude
organic extracts of cultured Udotea ﬂabellum on four human
malignant cell lines (HeLa, Hep-2, SiHa, and KB) and their
change over time under four light treatments. Furthermore,
the study evaluated whether phenol content and lipid
composition were related to its antiproliferative activity.
2.MaterialsandMethods
2.1.Alga Collection andCulture Conditions. Udoteaﬂabellum
(J. Ellis and Solander) M. A. Howe were collected along
the YUC Peninsula coast, Mexico, stored in plastic bags and
chilled in ice during transport to the Cinvestav Marine Sta-
tionatTelchac,Yucatan,Mexico.Algaewerecultivatedunder
four light treatments: full (100%) sunlight, 75% sunlight,
50% sunlight, and 0% sunlight, designated treatment A, B,
C, and D, respectively. Agricultural greenhouse shade net
was used in order to obtain variable light intensities in the
culture system. Light intensity varied over cultivation time:
during the ﬁrst 10 days, the photon ﬂux density (PFD) in full
sunlight and 75% sunlight treatments were not signiﬁcantly
diﬀerent (one-way ANOVA, F[3,36] = 68.21, P<0.0001;
post hoc Tukey’s test P<0.0001) at 55 ± 12.9a n d6 5±
12.5μmol photon m−2s−1, respectively, while 50, and 0%
treatments received 60, and 3% of incident PFD, respectively
(42 ± 12.0a n d2± 0.7μmol photon m−2s−1). After 20 and
30 days of cultivation, a similar trend was registered, with
the 75% treatment receiving 75–100% of incident PFD and
the 50% treatment receiving 42–52%; the 0% treatment only
received 2% of incident PFD (Figure 1).
2.2. Preparation of Extracts. Freshly collected samples of the
wild material were lyophilized and ground into powder to
perform plant extraction protocols and analytical methods;
this material was considered as a control before cultivation
(time 0). Entire plants (n = 15) were taken from each
culture treatment—A, B, C, and D—at 10, 20, and 30 days
into the experimental period to perform organic extraction
and analysis. Lyophilized samples (20g) were exhaustively
extracted with 200mL of dichloromethane: methanol (7:3)
by maceration for 24h at room temperature. These extracts
were ﬁltered and concentrated to dryness in vacuum at 40◦C
and stored at −20◦C until required. Every extract was labeled
according to culture conditions: light intensity (A, B, C, or
D) and time (10, 20, and 30 days).
2.3. Chemicals. Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM), heat-inactivated fetal bovine serum (FBS) and
penicillin and streptomycin (PS) were purchased from
Gibco, USA. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tet-
razolium bromide (MTT), Dimethyl sulfoxide (DMSO),
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Figure 1: Photon ﬂux density during cultivation of U. ﬂabellum.
(A) full sunlight (100 %), (B) 75 % sunlight, (C) 50 % sunlight, and
(D) 0 % sunlight. Asterisk indicates signiﬁcant diﬀerences.
sulforhodamine B (SRB) and trichloroacetic acid (TCA)
were obtained from Sigma.
2.4. Cell Culture. The following cell lines were used for the
antiproliferative assays: normal Mardin-Darbin cell kidney
(MDCK), and four human carcinoma cells, namely, laryn-
geal (Hep-2), cervix (HeLa), cervix squamous (SiHa) and
nasopharynx (KB). The cells were grown in DMEM media
supplemented with 10% v/v fetal bovine serum (FBS) with
100UmgmL−1 of PS. Cell lines were maintained at 37◦Ci n
a5 %C O 2 atmosphere with 95% humidity, and the culture
medium was changed once every 5 days.
2.5.CytotoxicityAssay. Thecytotoxicityassaywasperformed
according to Rahman et al. [16], where 1.5 × 104 viable
cells from each cell line were seeded in a 96-well plate
and incubated for 24 to 48h. When cells reached >80 %
conﬂuence, the medium was replaced and the cells were
treated with the organic extracts dissolved in dimethyl
sulfoxide (DMSO at a maximum concentration of 0.05%)
at 6.25, 12.5, 25, and 50μgmL −1. After 72h of incubation,
10μL of MTT solution (5mgmL−1) was added to each well
andincubatedat37◦Cfor4h.Themediumwasremovedand
formazan, generated by the activity of dehydrogenases, was
dissolved in acidiﬁed isopropanol (0.4NHCl). The amount
of MTT-formazan generated is directly proportional to the
number of living cells and was determined by measuring
the optical density (OD) at 540nm using a Bio-assay reader
(BioRad, USA). Untreated cells were used as a negative
control. The concentration of the organic extract that killed
50% of the cells (CC50) was calculated with GraphPad-
PRISM 4.00 software. All determinations were performed in
triplicate.
2.6.AntiproliferativeAssay. Fortheantiproliferativeassay,we
used sulforhodamine B (SRB), a colorimetric assay which
estimates cell number by staining total cellular protein withEvidence-Based Complementary and Alternative Medicine 3
the SRB dye, in order to assess cell growth inhibition [16].
This method used the same conditions as the cytotoxic assay
except that the medium was replaced with DMEM 10% FBS
to induce cellular proliferation during extract treatments.
After 48h incubation, the medium was discarded and cells
were ﬁxed with 100μL of ice-cold 40% TCA. Thereafter, the
cellswereincubatedat4◦Cfor1handtheplateswerewashed
ﬁ v et i m e sw i t hc o l dw a t e r .T h ee x c e s sw a t e rw a sd r a i n e do ﬀ
and the plates were left to dry; 50μL of SRB stain (10mg w/v
in 1% acetic acid) was added to each well for 30min. Finally,
the plates were washed with 50mL of 1% acetic acid and
rinsedfourtimesuntildyeadheringtothecellswasobserved.
The OD was measured at 540nm using a microplate reader
(model 450, Bio-Rad, USA). Untreated cells were used as
a negative control. Docetaxel, a clinically well-established
antimitotic chemotherapy medication was used as a positive
control of antiproliferative activity. The IC50 value, that is,
the concentration of organic extract that produced a 50%
reduction in the surviving fraction, was calculated using
GraphPad-PRISM 4.00 software. MDCK cell line was used
to evaluate the selective index (SI) of U. ﬂabellum extracts. SI
isdeﬁnedastheratioofcytotoxictoantiproliferativeactivity.
All determinations were performed in triplicate.
2.7. Phenolic Content. Total phenolic content of the algal
extractswasdetermined spectrophotometricallyusing Folin-
Ciocalteu reagent [17]. First, 20mg of the dry extract
was diluted with methanol (3mL). Aliquots of the diluted
extracts (0.1mL) were transferred into the test tubes; 2.9mL
of distilled water and 0.5mL of Folin-Ciocalteu reagent
were added. After 10min, 1.5mL of 20% sodium carbonate
solution was added, mixed thoroughly and allowed to stand
at room temperature in the dark for 1h. Absorbance was
measured at 725nm and total phenolic content (expressed
as % of dry weight) was calculated based on a standard curve
of phloroglucinol.
2.8.LipidContent. Totallipids weredetermined accordingto
apreviouslyreportedmethod[18].Thealgaeextract(20mg)
was homogenized with a mixture of H2O, methanol and
chloroform (1:1:9v/v). The chloroform layer containing
dissolved lipids was collected, dried with nitrogen, and
saponiﬁed with 1.2MNaOH. Fatty acids were converted
to methyl esters with 0.6mL of 10M HCl and 1mL of
12% boron trichloride in methanol at 80◦C for 60min.
After methylation, 1mL of hexane: diethylether (1:1) and
3mL of 0.3MNaOH were added, and the resultant mixture
was dried with nitrogen and recovered with hexane. The
total content of fatty acid methyl esters was analyzed
by gas chromatography (Hewlett Packard 6890 Plus with
Supelco SP2560 bis-cyanopropyl polysiloxane capillary col-
umn 100m × 0.25mm × 0.25μm internal diameter). The
column temperature programming was set from 140 (5min)
to 240◦C (20min) at a rate of 4◦Cm i n −1. Injector and
detector temperature was 260◦C. Helium was used as the
carrier gas at a ﬂow rate of 1.1mLmin−1.F a t t ya c i d
methyl esters were identiﬁed by comparing their retention
times with those of standard samples. The lipid analyses
were carried out in duplicate, and the results expressed as
percentages of algae extract dry weight (% dry wt).
2.9. Statistical Analysis. Data were analyzed with GraphPad
4.0 Software Inc. (San Diego, Calif, USA). The dose-response
curves (variable slope) were ﬁtted with the algorithm: Y =
Emin +[(Emax Emin)/(1+10(LogED50−LogD) Hill slope)].
Statistical analysis was performed with parametric tests
because variances were homogeneous between groups. An
unpaired Student’s t-test (two-tailed) was applied when only
two groups were compared. A one-way ANOVA followed by
post hoc Dunnett’s test was used to assess the diﬀerences
when three or more groups were simultaneously compared.
Values in text and ﬁgures are expressed as means ± SD.
3. Results
3.1. Antiproliferative Activity. The antiproliferative activity
of U. ﬂabellum extracts on the growth of four cancer cells
in vitro are summarized in Table 1. The organic extract of
wild U. ﬂabellum collected (time 0) showed antiprolifera-
tive activity (IC50) on SiHa (276.2 ± 1.9μgmL −1), HeLa
(296.6 ± 0.9μgmL −1), Hep-2 (52.9 ± 1.0μgmL −1), and KB
(47.8 ± 1.2μgmL −1). After10 and 20 days of cultivation, the
antiproliferative activity of the U. ﬂabellum extracts on the
SiHa cell line signiﬁcantly improved when compared with
nonculturedU.ﬂabellum extracts(IC50 276.2μgmL −1),with
a reduction of 85–95% after 10 days and 63–77% after 20
days of cultivation. The antiproliferative activity of extracts
on the HeLa cell line had the same tendency, with a 70–
90%reductionofthenonculturedU. ﬂabellum extractsIC50;
whereas extracts obtained after 30 days of culture increased
IC50 by approximately 78–185% and 40–95% on the SiHa
and HeLa cell lines, respectively. For the Hep-2 and KB cell
lines U. ﬂabellum extracts only showed a 36–69% and 40–
51% reduction of IC50 after 10 days of cultivation.
Ingeneral,U.ﬂabellumextractsobtainedaftercultivation
showed improved SI on cancer cells, particularly the extracts
from culture treatment A (10 days), which showed the
highest selectivity index ranging from 6–28 and 8–20 on the
SiHa and Hep-2 cell lines, respectively (Table 2).
3.2. Phenol and Lipid Content. U. ﬂabellum extracts before
cultivation (time 0) showed a total phenol content of 1.7 ±
0.2%drywt.U. ﬂabellum extractsincreasedphenoliccontent
by 100% for all treatments after 10 and 20 days of cultivation
(Figure 2(a)). Lipid and fatty acid content in U. ﬂabellum
extracts varied in relation to time and light availability
(Figure 2(b)). U. ﬂabellum extracts before cultivation (time
0) showed a total lipid content of 46.4 ± 1.5%, increasing
by 60 and 70% after 20 and 30 days of cultivation with-
out light. GC analysis revealed that saturated fatty acids
(SAFA) were dominant (58.6%) while monounsaturated
fatty acid (MUFA) and polyunsaturated fatty acid (PUFA)
were present at 14.2% and 27.1%, respectively (Figure 2(c)).
In general, after cultivation SAFA content decreased by
6–19% in relation to the control while MUFA content
remainedsimilarthroughouttimeandcultivationtreatment.4 Evidence-Based Complementary and Alternative Medicine
Table 1: Growth inhibition (IC50)o fU. ﬂabellum extracts on cancer cell lines (P ≤ 0.001).
Cancer cells IC50±SD (μgmL −1)
Time = 0D a y = 10 Day = 20 Day = 30
SiHa 276.2 ±1.91
A3 0 .4 ±3.9 100.6 ±2.65 493.1 ±2.1
B4 2 .7 ±0.97 5 .8 ±1.1 623.3 ±2.7
C1 0 .2 ±1.26 4 .5 ±1.5 788.9 ±1.2
D 13.1 ±2.76 2 .4 ±1.2 547.8 ±2.1
F(4,10) = 6814 F(4,10) = 8113 F(4,10) = 24910
Docetaxel 0.32 ±0.01
HeLa 296.6 ±0.9
A4 9 .7 ±2.14 5 .3 ±1.3 413.6 ±0.9
B3 9 .2 ±3.13 4 .8 ±1.9 580.4 ±1.9
C5 3 .8 ±2.76 7 .4 ±2.8 568.2 ±1.2
D 63.8 ±1.87 6 .6 ±1.8 482.6 ±0.9
F(4,10) = 7143 F(4,10) = 10350 F(4,10) = 27690
Docetaxel 0.20 ±0.04
Hep-2 52.9 ±1
A1 6 .6 ±1.37 1 .7 ±2.19 8 .4 ±1.2
B1 9 .1 ±1.86 0 .3 ±1.8 100.7 ±1.8
C1 6 .7 ±0.97 5 .2 ±1.99 1 .5 ±2.3
D 33.5 ±1.49 1 .1 ±1.9 106.1 ±1.6
F(4,10) = 424.1 F(4,10) = 203.4 F(4,10) = 521.7
Docetaxel 0.08 ±0.03
KB 47.8 ±1.2
A2 3 .4 ±1.9 134.6 ±1.9 106.4 ±1.5
B2 9 .8 ±2.1 138.1 ±1.5 109.7 ±1.5
C3 2 .4 ±1.7 117.3 ±1.2 123.4 ±0 .9
D 28.9 ±1.2 112.7 ±1.4 126.7 ±2.3
F(4,10) = 113.9 F(4,10) = 1854 F(4,10) = 1269
Docetaxel 0.23 ±0.07
IC50: half maximal (50%) inhibitory concentration (IC) of organic extracts.
Table 2: Cytotoxicity (CC50)o fU. ﬂabellum extracts on normal cell line and selective index (SI) for each cancer cell line.
Time (Irradiance treatment) CC50 MDCK Cells SI
SiHa HeLa Hep-2 KB
Time = 0 297.9±11.2
Day = 10
A 322.3 ± 8.9 10 6.5 19.4 13.7
B 272.6 ± 4.1 6.4 7.0 14.5 9.3
C 286.6 ± 5.1 28 5.3 17.1 8.8
D 276.9 ± 5.8 21 4.3 8.2 9.6
Day = 20
A 358.2 ± 2.9 3.6 7.9 5.0 2.6
B 323.3 ± 4.6 4.3 9.2 5.4 2.3
C 375.9 ± 6.7 5.8 5.5 5.0 3.2
D 386.1 ±7.1 6.0 5.0 4.2 3.4
Day = 30
A 528.4 ± 10.2 1.0 1.0 5.4 5.0
B 436.3 ± 9.6 0.5 6.7 4.3 4.0
C 524.8 ± 8.6 0.6 0.9 5.7 4.2
D 424.4 ± 7.8 0.7 0.8 4.0 3.3
CC50: mean concentration that killed 50% of cells; SI = ratio of cytotoxic to antiproliferative activity.Evidence-Based Complementary and Alternative Medicine 5
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Figure 2: Phenol and lipid content of Udotea ﬂabellum extracts. (a) Total phenol content expressed as a percentage of the control (%), (b)
lipid content in organic extracts expressed as a percentage of the control (%), (c) fatty acid composition in organic extracts expressed in %
dry weight (d wt) over the culture period. Each symbol is the mean±SD of three assays, normalized with the control extract collected at the
same time and place without culture treatment. Time when the samples were collected from the culture tank: 10, 20, and 30 days.
On the other hand, PUFA content increased 3–15% in
plants subjected to culture treatments when compared to the
control. The predominant SAFA was palmitic acid (16:0),
while in the MUFA fraction palmitoleic acid (C16:1) and
oleic acid (C18:1) predominated.
4. Discussion
Underexperimentalcultureconditionsthebiologicalactivity
of the U. ﬂabellum organic extracts improved, showing an
increased inhibitory eﬀect with a reduction in the initial
IC50, thus improving the eﬀect of culture conditions on
biological activity (Figure 3). U. ﬂabellum extracts obtained
after cultivation also improved SI on cancer cells, par-
ticularly on the SiHa and Hep-2 cell lines. According to
the American National Cancer Institute, the IC50 limit in
order to consider a crude extract promising for further
puriﬁcation is <30μgmL −1 [19]. Considering the above-
mentioned criterion, after 10 days of cultivation all U.
ﬂabellumextractsincreasedtheiractivityagainstSiHa,Hep-2
and KB cells.
U. ﬂabellum extracts increased phenolic content by 100%
for all treatments after 10 and 20 days of cultivation. In
this study, the inhibition of cancer cell proliferation by
U. ﬂabellum extracts could not be explained solely by the
concentration of polyphenolic compounds. This suggests
that other phytochemicals may play a major role in the
antiproliferative activity of U. ﬂabellum extracts. Previous
studies on tropical green algae of the family Udoteaceae have
isolated sesquiterpenoids and diterpenoids with biological
activity [20] and udoteatrial hydrate with moderate antimi-
crobial activity against Staphylococcus aureus [21].6 Evidence-Based Complementary and Alternative Medicine
L
i
p
i
d
c
o
n
t
e
n
t
Antiproliferative activity
Cultivation time
P
h
e
n
o
l
c
o
n
t
e
n
t
Figure3:EﬀectsofcultureconditionsandlightonUdoteaﬂabellum
chemical composition and their role in the antiproliferative activity
in cancerous cell lines in vitro. Increasing light promotes an
increase in phenolic compounds, whereas, lipid content decreases.
Therefore,algaeextractsincreasesantiproliferativeactivityforSiHa,
HeLa, Hep-2 and KB cells with time under controlled culture
conditions.
Phenolic compounds have been under study as potential
therapeutic agents against a wide range of diseases including
neurodegenerative diseases, cancer, diabetes, cardiovascular
dysfunction, inﬂammatory diseases, and aging [22]. In some
cases the antiproliferative activity of alga extracts has been
positively correlated with total polyphenol content, suggest-
ing a causal link between extract content of polyphenols and
phenolic acids [14]. This causal link has also been found
with the cytotoxicity in vitro of some red and brown algae
extracts [23, 24]. Moreover, phenolic compounds including
phlorotanninscaninduceoxidativestressincancercells[25].
The above could explain the ability of some algae extracts,
such as those from Lithothamnion calcareum, to suppress
c o l o np o l y pf o r m a t i o ni nm i c e[ 26].
In general, U. ﬂabellum extracts had high levels of
PUFA (linoleic acid and alpha linoleic acid). A variety of
fatty acids and derivatives have antiproliferative eﬀects in
diﬀerent cancer cell models [15]. Despite the amount of
useful information derived from lipid class analyses in algal
physiology, most of the studies available are restricted to
microalgae, and little is known about lipid class changes in
macroalgae during cultivation.
5. Conclusions
The results of this study indicate that the metabolism of a
numberofactivecompoundsofU.ﬂabellumaresubstantially
inﬂuenced by culture time but not light treatments, and
hence have an inﬂuence on the production of metabolites
that render them biologically active. Extracts obtained from
U. ﬂabellum after 10 and 20 days of culture under conditions
described in this study showed increased antiproliferative
activity on SiHa, HeLa, Hep-2 and KB cells. Although we
observed that culture time inﬂuenced phenol and lipid
content, the compound responsible for the antiproliferative
activity of U. ﬂabellum extracts remains to be identiﬁed.
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